Simultaneously, the different KIT exon 11 mutations such as point mutations, compound mutations and deletion mutations were not different based on gender, age, tumor location, CD117, CD34, DOG-1, bleeding or necrosis. This evidence concerns the gene ANO1 and neoplasm.